LUCIUS 卢修斯 他泽司他 Tazemetostat上皮样肉瘤 淋巴瘤

他泽司他

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品
Tazemetostat
老挝国家食药监局批准上市
老挝国家药检所检测认证
上皮样肉瘤

om positien:
azemetostat
110

LUCIUS

PHARMACEUTICALS

Lucilaze is a methyitransterase inhibitor indicated

淋巴瘤

Tor the treatrent of
a padialrsc patients aged 16 years and olde
with metastatie or locally advaneal .. l .. 1
na not eligible for comolete resection

LuciTaze

ymphoma whose lumore snno
mutation as detected

or refractory follicula
ected by an FDA-acproved test
* Adult patients with relapsed or refractory folliculat

Tazemetostat Tablets

lymphoma who have no satisfactory altermative
kreatment options

200mg

FDA批准

DesageandIluw
*Kecommended do
dosage ir 500 mgtaken orally twice
danly with or without food.
Swallow tablets whole. Do not eut, crush, or ches
Storage: in a dry place and store at 20°C to 25°C.

56 Tablets

Warning:

Adesrister Lnc Toze hirine Preenarcy and Lactation
ine out of seach of Children. Do net
PLEASE SEE PACKAGE INSERT
Manufactured and Marketed b
LUCIUS

权威认证

Thongmang village. Xaythany district
Vientiane Capital, Laos
www.luciusl
Warning: To be sold by retal on prescrintion
ol registered pliysicians only, and as directed

Rx only

口碑质量

适应症:

他泽司他是一种甲基转移酶抑制剂,适用于治疗:
·患有转移性或局部晚期上皮样肉瘤且不适合完全切除的16岁及
以上成人和儿童患者。
·患有复发性或难治性滤泡性淋巴瘤的成人患者,经FDA批准的检测
方法检出肿瘤呈EZH2突变阳性,且之前接受过至少2次全身治疗。
·患有复发性或难治性滤泡性淋巴瘤且没有令人满意的替代治疗
方案的成人患者。
推荐剂量:
每日口服两次,每次800mg,可与食物同服或单独服用。